C. Carter

Genetic, transcriptome, proteomic and epidemiological evidence for blood brain barrier disruption and polymicrobial brain invasion as determinant factors in Alzheimer’s disease

C. Carter, 2016, bioRxiv.

Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer

M. Reyland, B. Allen-Petersen, C. J. Carter, 2014, Oncogene.

Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants

S. Murray, A. Bauer, M. Cunningham, 2022, Disease models & mechanisms.

Loss of PKCδ results in characteristics of Sjögren's syndrome including salivary gland dysfunction.

Kaleb M. Pauley, S. Anderson, S. Anderson, 2011, Oral diseases.

Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.

W. Franklin, L. Heasley, M. Reyland, 2011, Cancer research.